Profile, PFE in validation deal

Profile Therapeutics (LSE:PTP) granted Pfizer (PFE) a license to its inhaler technology to validate an undisclosed preclinical PFE respiratory disease therapeutic. PFE also will use PTP's Adaptive Aer...